| Terms of Use |  Privacy Policy |

Copyright(C)2001-2014 Nutrition Act Co.,Ltd. All Rights Reserved.

 

HOME Business > Ingredient Materials > Liquamen >Liquamen: Detailed Information

Liquamen: Detailed Information

  • DATA- 1 Benefits observed in patients who used liquamen for 10 years

  • DATA- 2 Direct evaluation of atherosclerosis risk (IMT)

  • DATA- 3 Experimental study concerning mental and memory abilities

  • DATA- 4 Experimental study on learning processes

  • DATA- 5  Levels of hormones (ACTH, adrenalin, GABA) in rats under environmental stress

DATA-1
Benefits observed in patients who used liquamen for 10 years
Results

Liquamen took effect 2 months after the beginning of use. The level of improvement was maintained and amplified in subsequent months. No biological or clinical side effects were noted on the tests for liver and kidney functions and hemostasis.

Department of Vascular Function, Faculty of Medicine at Saint-Antoine Campus, Pierre and Marie Curie University - Paris 6

Tenon Hospital

CIEM Laboratory

DATA-2
Direct evaluation of atherosclerosis risk (IMT)
Summary

A consequence of dyslipidemia and other abnormal conditions is the aging of blood vessels, most notably the development of atherosclerosis characterized by the thickening and hardening of the inner layer of arterial walls.

Pharmaceutical interventions aim at the reduction of cardiovascular risks measured by the improvement of incident rates as an end point.

This liquamen study evaluated the progression of atherosclerosis using IMT, a measure of the wall thickness of the carotid artery. The group who took liquamen, in comparison with the placebo and fish oil groups, was found to have smaller blood vessel wall thickness (carotid artery intima-media thickness).

Results

Based on the result of this study, liquamen is expected to reduce the risk of developing atherosclerosis.

Experimental study concerning mental and memory abilities
DATA-3
Summary of a clinical study of liquamen neuropeptides in humans
Summary

The purpose of this study was to examine the effect of liquamen in enhancing the mental and memory abilities of human subjects in comparison with placebo under matching conditions.

M. Le Poncin, PhD.; I. Lampreglow[hp031] , PhD.; F. Juoan, geriatrician

INRPVC: ANTENNE INST NAT RECH PREV VIEILL CEREBR

European Neuropsychopharmacology, June 1996

Results

The results of this study proved the “memory enhancement” effect of liquamen capsules. This effect was significant, as the placebo group and the liquamen group were identical at the baseline. The observation in this study led to the conclusion that liquamen as a dietary supplement is useful for psychiatric health and mental alertness and, more importantly, improves shot- and long-term memory processes. These clinical study results were consistent with the results of previous studies.

DATA-4
Experimental study on learning processes
Summary of clinical study of liquamen neuropeptides in rats 1
Summary

The purpose of this study (experiment approval No. 005470) was to examine the learning ability of rats using water maze tests after administration of a substance called liquamen. The tests were conducted using a method approved by FDA and employed commonly for the confirmation of the action of substances to promote learning and memory.

I. LAMPREGLOW
BICHAT MEDICAL SCHOOL

Results

Liquamen neuropeptides showed effective reactions. The rats treated with liquamen learned escape routes from water mazes much more quickly than control rats.

DATA-5
Levels of hormones (ACTH, adrenalin, GABA) in rats under environmental stress
Summary of clinical study of liquamen neuropeptides in rats 2
Summary

The purpose of this study was to characterize the actions of a nutritional product called liquamen on “inhibitory hormones” such as ACTH (adrenocorticotropic hormone), “stress hormones” such as adrenalin, and “calming neurohormones” such as GABA (gamma-aminobutylic acid). Rats were subjected to 2 types of stress and results were compared among 3 treatment groups.

Professor J. P. Dupouy

Neuroendocrinologie du Dévelopment, Université des Sciences & Techniques de Lille Flandres Artois (USTL)

Psychopharmacology[hp031] , March 2000.

Results

The measurement of hormones in blood and cerebral tissues under stress showed that ACTH, adrenalin, and GABA were reduced significantly by liquamen and Valium (an anti-stress drug). Present data suggest Valium-like effects of liquamen on stress responsiveness.